Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
790.00    -4.00 (-0.50%)
Bid:
784.00
Ask:
808.00
Spread: 24.00 (3.061%)
Market Cap: £364.16m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close trading update

1 Dec 2014 07:00

RNS Number : 3904Y
Porvair PLC
01 December 2014
 



For immediate release 1 December 2014

 

 

 

Pre-close trading update

 

Porvair ("Porvair" or "the Group"), the specialist filtration and environmental technologies group, makes the following announcement regarding trading for the year ended 30 November 2014 ahead of its close period.

 

Porvair has continued to trade strongly throughout the year. Both divisions are expected to deliver record results, with revenue for the full year up 24% (28% at constant exchange rates) and earnings marginally ahead of current market expectations.

 

Strong operating cash flow has increased net cash at the year end to around £5m, achieved after capital investments of £5m, mostly spent on expanding manufacturing capacity to meet demand.

 

As anticipated in previous announcements, Group revenue in 2014 received a one-off boost of £20m (2013: £6m) from several large contracts, each of which is proceeding as expected. Profits on these contracts are recognised after making appropriate allowance for the outstanding liabilities, potential risks and warranties. Consequently, we expect further profits to be achieved as milestones are successfully passed over the period to 2017.

 

Revenue in the Microfiltration division was 34% (36% at constant exchange rates) ahead of the prior year. Underlying revenue growth, excluding the impact of the large projects mentioned above, was 9% (11% at constant exchange rates). Aerospace revenue continued to grow steadily and Seal Analytical recorded a record result for the year.

 

Revenue in the Metals Filtration division was 5% (11% at constant exchange rates) ahead of the prior year. Market share gains continued to be made, particularly in iron foundry filtration. The new plant in Wuhan, China, is performing as expected and revenue from aluminium filtration in China was strong.

 

The Group has adopted IAS19 Revised, Employee Benefits, in the year ended 30 November 2014. This increases the defined benefit pension scheme costs charged in the accounts and requires a revision of prior years. Earnings per share for the year ended 30 November 2013, the comparative period, are restated at 12.3 pence compared with the previously reported 12.7 pence.

 

Order books for the start of 2015 are healthy and the Group has a promising pipeline of potential projects.

 

Porvair will announce its preliminary results for the year ended 30 November 2014 on Monday 26 January 2015.

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration and environmental technology businesses. Its products are used in a range of niche filtration markets, and are derived from its expertise in the design and manufacture of filtration systems using ceramic, metal, plastic and carbon media. Its Seal Analytical business is a market leader in the manufacture of laboratory based water analysis equipment.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFLZFFLFBK
Date   Source Headline
14th Feb 201812:02 pmRNSPrice Monitoring Extension
13th Feb 20184:40 pmRNSSecond Price Monitoring Extn
13th Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20185:57 pmRNSBlock listing Interim Review
29th Jan 20187:00 amRNSResults for the year ended 30 November 2017
2nd Jan 201810:35 amRNSHolding(s) in Company
12th Dec 20174:52 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSPre-close Trading Update and Acquisition
6th Nov 20174:40 pmRNSSecond Price Monitoring Extn
6th Nov 20174:35 pmRNSPrice Monitoring Extension
18th Oct 20174:35 pmRNSPrice Monitoring Extension
13th Oct 201710:00 amRNSDirector's Shareholding and Issue of Equity
10th Oct 20178:27 amRNSHolding(s) in Company
3rd Oct 20174:35 pmRNSPrice Monitoring Extension
28th Sep 20177:00 amRNSAppointment of an Independent NED
19th Sep 20177:00 amRNSTrading Update
17th Aug 201711:34 amRNSHolding(s) in Company
28th Jun 201712:32 pmRNSDirector's Shareholding and Issue of Equity
27th Jun 20177:00 amRNSHalf Yearly Results
22nd Jun 201710:00 amRNSAdditional Listing
5th Jun 20177:00 amRNSTrading Update
11th Apr 201711:50 amRNSAGM resolutions
11th Apr 20177:00 amRNSAGM Statement and Trading Update
10th Apr 20174:51 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSAcquisition
24th Mar 20178:00 amRNSDirector's Shareholding and Issue of Equity
10th Mar 201712:05 pmRNSPosting of Accounts, AGM and Change of Auditor
22nd Feb 201710:33 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSResults for the year ended 30 November 2016
26th Jan 20174:12 pmRNSHolding(s) in Company
6th Dec 20167:00 amRNSTrading Update and Directorate Change
30th Nov 20168:21 amRNSDirector's shareholding and changes in equity
14th Nov 201610:28 amRNSDr Krishnamurthy Rajagopal
10th Nov 20165:09 pmRNSHolding(s) in Company
3rd Oct 20164:06 pmRNSHolding(s) in Company
3rd Oct 20164:04 pmRNSHolding(s) in Company
3rd Oct 201610:29 amRNSHolding(s) in Company
21st Sep 201612:07 pmRNSSecond Price Monitoring Extn
21st Sep 201612:02 pmRNSPrice Monitoring Extension
21st Sep 20169:28 amRNSHolding(s) in Company
21st Sep 20167:00 amRNSTrading update & appointment of an Independent NED
27th Jun 20167:00 amRNSHalf yearly results
16th Jun 20163:49 pmRNSHolding(s) in Company
16th Jun 20163:48 pmRNSHolding(s) in Company
16th Jun 201611:02 amRNSHolding(s) in Company
2nd Jun 20167:00 amRNSTrading Update
17th May 20163:19 pmRNSHolding(s) in Company
17th May 20163:18 pmRNSHolding(s) in Company
12th Apr 20162:51 pmRNSAGM resolutions
18th Mar 201612:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.